Antimicrobial Resistance of Gram-Negative Isolates from Intensive Care Units in Turkey: Comparison to Previous Three Years

dc.contributor.authorYücesoy, M.
dc.contributor.authorYuluğ, N.
dc.contributor.authorKocagöz, S.
dc.contributor.authorÜnal, S.
dc.contributor.authorÇetin, S.
dc.contributor.authorÇalangu, S.
dc.date.accessioned2020-03-26T16:36:12Z
dc.date.available2020-03-26T16:36:12Z
dc.date.issued2000
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractResistance rates to selected antibiotics of Gram-negative bacteria isolated from intensive care units (ICU) of 16 Turkish hospitals during 1998 were evaluated and compared to data from the previous 3 years. Antibiotic susceptibilities to imipenem, ceftazidime, ceftazidime-clavulanate, cefoperazone-sulbactam, ceftriaxone, cefepime, cefodizime, cefuroxime, piperacillin-tazobactam, ticarcillin-clavulanate, gentamicin, amikacin and ciprofloxacin were determined by Etest, A total of 1,404 isolates from 1,060 patients were collected, mainly from urinary and respiratory tracts. As in the previous 3 years, Pseudomonas spp, was the most frequently isolated Gram-negative species (29.7%), followed by Escherichia coli, Acinetobacter and Klebsiella spp, Imipenem was the most active in vitro agent (73.4% susceptible), followed by ciprofloxacin (60.6%), cefoperazone-sulbactam (58.7%), cefepime (56.7%), piperacillin-tazobactam (55.0%) and amikacin (54.7%), In 1996, a decline in susceptibility rates of all antibiotics was evident. With the exception of imipenem, resistance to which remained stable, rates somewhat increased in 1997. In 1998, susceptibility to imipenem and cefepime remained stable, amikacin resistance tended to increase and susceptibility rates to other antibacterials showed a favorable increase. These results may in part be due to the implementation of a surveillance program and increased understanding of the magnitude of the resistance problem.en_US
dc.identifier.citationYücesoy, M., Yuluğ, N., Kocagöz, S., Ünal, S., Çetin, S., Çalangu, S., (2000). Antimicrobial Resistance of Gram-Negative Isolates from Intensive Care Units in Turkey: Comparison to Previous Three Years. Journal of Chemotherapy, 12(4), 294-298. Doi: 10.1179/joc.2000.12.4.294
dc.identifier.endpage298en_US
dc.identifier.issn1120-009Xen_US
dc.identifier.issue4en_US
dc.identifier.startpage294en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/17184
dc.identifier.volume12en_US
dc.identifier.wosWOS:000166156600019en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherE I F T Srlen_US
dc.relation.ispartofJournal of Chemotherapyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectantimicrobial susceptibilityen_US
dc.subjectintensive care uniten_US
dc.subjectresistanceen_US
dc.titleAntimicrobial Resistance of Gram-Negative Isolates from Intensive Care Units in Turkey: Comparison to Previous Three Yearsen_US
dc.typeCorrectionen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
7184.pdf
Boyut:
364.29 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası